Moderna, Inc. (MRNA)
Moderna, Inc. Net Income
| Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|
| Net Income | ($216.2M) | ($255.9M) | ($384.7M) | ($514.0M) | ($747.1M) | $12.2B | $8,362.0M | ($4,714.0M) |
Moderna, Inc. (MRNA) Net Income comparison analysis
MRNA key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Moderna, Inc.'s Net Income?
As of today, Moderna, Inc.'s last 12-month Net Income is ($2,224.0M), based on the financial report for Sep 30, 2024 (Q3 2024).
2) What is Moderna, Inc.'s Net Income growth rate?
Over the last year, Moderna, Inc.'s Net Income growth was (35.8%). The average annual Net Income growth rates for Moderna, Inc. have been N/A over the past three years, 33.2% over the past five years.
3) Is Moderna, Inc.'s Net Income growth rate Good?
Over the last year, Moderna, Inc.'s Net Income growth was (35.8%), which is lower than industry growth of (0.1%). It indicates that Moderna, Inc.'s Net Income growth is Bad.